Home › Funds › Birchview Capital, LP › ADAG

Birchview Capital, LP position in ADAG

ADAGENE INC · Health Care

Birchview Capital, LP reported holding 430,000 shares of ADAG (ADAGENE INC) in its Q3 2026 13F filing — a position valued at US$1.4M, representing 0.82% of its reported portfolio and ranking #30 among its reported holdings. Birchview Capital, LP has disclosed ADAG holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)430.00K sh
Reported value held$1.38M
Portfolio Weight0.82%
First reportedQ2 2026
Last changeAdd
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Birchview Capital, LP's ADAG position evolved

Birchview Capital, LP first disclosed a stake in ADAG in Q2 2026 at 240,000 shares (US$1.0M). The position peaked in Q3 2026 at 430,000 shares, worth US$1.4M. Across 2 filings, Birchview Capital, LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 430,000 shares valued at US$1.4M — an increase of 190,000 shares quarter over quarter.. Notable position changes include a 79% increase in Q3 2026 (shares fell 47% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2026 240.00K $1.01M New
Q3 2026 430.00K $1.38M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ADAG and 13F data

ADAG (ADAGENE INC) is a Health Care company. 39 other funds we track also report a position in ADAG — the largest reported positions include Squadron Capital Management LLC (US$5.2M), HSG Holding Ltd (US$4.3M), Dauntless Investment Group, LLC (US$2.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ADAG

All ADAG fund holders →

FAQ

How long has Birchview Capital, LP held ADAG?

Birchview Capital, LP has disclosed ADAG holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Birchview Capital, LP's current position in ADAG?

As of Q3 2026, Birchview Capital, LP holds 430.00K shares of ADAG (ADAGENE INC), valued at $1.38M, representing 0.82% of its reported portfolio and ranking #30.

Has Birchview Capital, LP been buying or selling ADAG?

In the latest 13F filing (Q3 2026), Birchview Capital, LP increased its position in ADAG. The position peaked in Q3 2026 at 430.00K shares.

Which other funds hold ADAG?

Other major institutional holders of ADAG include Squadron Capital Management LLC, HSG Holding Ltd, Dauntless Investment Group, LLC, among 39 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.